Two-Colour Fluorescence Marker for Neurodegenerative Diseases
Worldwide it is estimated that there are 29 million cases of Alzheimer Disease (AD) and about 4 million of Parkinson's Disease (PD). The world market for AD and PD is estimated to be 14 billion dollars corresponding to an annual growth rate of 20%, making it an very attractive field for R&D to generate novel therapeuticals. Recently, the accumulation of dysfunctional mitochondria has been linked to neurodegenerative diseases, in particular to AD and PD. Scientists at the University of Göttingen have developed a powerful fluorescent marker for Live Cell Imaging to study mitochondrial dysfunctions and for testing novel pharmaceutical products
Further Information: PDF
MBM ScienceBridge GmbH
Phone: (0551) 30724-152
Contact
Dr. Jens-Peter Horst
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Solving the riddle of the sphingolipids in coronary artery disease
Weill Cornell Medicine investigators have uncovered a way to unleash in blood vessels the protective effects of a type of fat-related molecule known as a sphingolipid, suggesting a promising new…
Rocks with the oldest evidence yet of Earth’s magnetic field
The 3.7 billion-year-old rocks may extend the magnetic field’s age by 200 million years. Geologists at MIT and Oxford University have uncovered ancient rocks in Greenland that bear the oldest…
Decisive breakthrough for battery production
Storing and utilising energy with innovative sulphur-based cathodes. HU research team develops foundations for sustainable battery technology Electric vehicles and portable electronic devices such as laptops and mobile phones are…
